ftInvstr
BIOFILCHEM · Healthcare ₹31.85 -1.82% Mkt Cap ₹52 Cr
← Search another stock

BIOFILCHEM

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹31.85
-1.82% today · 30d -1.64%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for BIOFILCHEM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹12 Cr
+91.99% YoY
NET PROFIT
₹0 Cr
-95.47% YoY
OPM
1.64%
-28.99pp YoY
EPS
₹0.07
PE 106.8
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.5% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BIOFILCHEM106.8—
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
40
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth MUTED 49
Profitability AVERAGE 30
Technicals WEAK 47
Risk LOW 90
Key Stats
TTM PE
106.8
P/B
2.43
52W HIGH
₹46.34
OFF HIGH
-31.27%
MKT CAP
₹52 Cr
◉ Active Signals
MACDNeutral0.056
RSI(14)Neutral45.5
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BIOFILCHEM and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.